Sign In
Buy INMB
$1.32
-0.1000 (-7.04%)
At Close: Jun 03, 2026
INmune Bio Issues Equity Raise Of $40M At 18% Discount To Fund Alzheimer's Candidate Development
11:45am, Wednesday, 14'th Jul 2021
INmune Bio Inc (NASDAQ: INMB) has announced a direct offering of 1.8 million shares at $22.00 per share for gross proceeds of approximately $40 million. The offering will close by July 16.
INMUNE BIO, INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING
09:02am, Wednesday, 14'th Jul 2021
Boca Raton, FL., July 14, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune Bio”), a clinical-stage immunology company focused on developing treatments that ha
INmune Bio: Underfollowed AD Player With Very Bullish August Momentum
06:06pm, Tuesday, 13'th Jul 2021
With XPro1595, it has a disease-modifying drug candidate that has already shown to consistently decrease multiple biomarkers of neuroinflammation; The test is now how this affects biomarkers of neurod
INmune Bio Stock Increased 10.64%: Why It Happened
04:56pm, Wednesday, 07'th Jul 2021
The stock price of INmune Bio Inc (NASDAQ: INMB) increased by 10.64%. This is why it happened.
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce Future Dilution
04:01pm, Monday, 14'th Jun 2021
Purchase of Xencor Option potentially eliminates approximately 2.1 mill ion shares of INmune future common stock dilution upon execution.
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q1 2021 Results - Earnings Call Transcript
11:42pm, Wednesday, 05'th May 2021
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q1 2021 Results - Earnings Call Transcript
INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business Update
04:15pm, Wednesday, 05'th May 2021
Company to host conference call today, May 5, at 4:30pm ET Company to host conference call today, May 5, at 4:30pm ET
INmune Bio, Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, May 5
09:00am, Wednesday, 28'th Apr 2021
Management to host conference call at 4:30 pm ET on that day Management to host conference call at 4:30 pm ET on that day
INmune Bio: Harnessing The Power Of The Innate Immune System
04:52pm, Monday, 19'th Apr 2021
Based on the theory that chronic low-grade inflammation is behind many ailments, the company's therapies are setting out to enlist the innate immune system to combat these.
INMB Stock: Over 3% Increase Pre-Market Explanation
09:24am, Monday, 12'th Apr 2021
The stock price of INmune Bio Inc (NASDAQ: INMB) increased by over 3% pre-market. This is why it happened.
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q4 2020 Results - Earnings Call Transcript
10:17pm, Thursday, 04'th Mar 2021
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q4 2020 Results - Earnings Call Transcript
INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update
04:15pm, Thursday, 04'th Mar 2021
Company to host conference call today, March 4, at 4:30pm ET Company to host conference call today, March 4, at 4:30pm ET
Why INmune Bio Stock Soared Then Sank Today
03:53pm, Thursday, 21'st Jan 2021
The wild ride for the biotech stock started with its announcement of results from a phase 1b study.
Interim data show CSF biomarkers of neurodegeneration and synaptic dysfunction as well as neuroimaging biomarkers improved after three months of therapy with XPro1595
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday, January 21 at 8 AM ET
08:00am, Wednesday, 13'th Jan 2021
Webinar to review expanded biomarker data from the company's Phase 1b clinical trial of XPro1595 targeting neuroinflammation in patients with Alzheimer's disease
